Envestnet Asset Management Inc. Reduces Stock Position in Intuitive Surgical, Inc. $ISRG

Envestnet Asset Management Inc. reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.9% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 539,824 shares of the medical equipment provider’s stock after selling 27,536 shares during the period. Envestnet Asset Management Inc. owned approximately 0.15% of Intuitive Surgical worth $293,346,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Chilton Capital Management LLC boosted its stake in shares of Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. purchased a new position in shares of Intuitive Surgical during the 1st quarter worth about $26,000. Princeton Global Asset Management LLC purchased a new position in shares of Intuitive Surgical during the 2nd quarter worth about $30,000. LFA Lugano Financial Advisors SA purchased a new position in shares of Intuitive Surgical during the 1st quarter worth about $30,000. Finally, TD Capital Management LLC boosted its stake in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $546.51 on Monday. The firm has a market cap of $195.91 billion, a P/E ratio of 72.29, a P/E/G ratio of 5.02 and a beta of 1.61. The firm has a 50-day simple moving average of $458.09 and a 200-day simple moving average of $497.11. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.84 EPS. On average, research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on ISRG shares. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $599.00 to $600.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Daiwa Capital Markets lifted their price objective on shares of Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a report on Friday. Robert W. Baird set a $655.00 price objective on shares of Intuitive Surgical in a report on Wednesday. Rothschild & Co Redburn lifted their price objective on shares of Intuitive Surgical from $610.00 to $615.00 and gave the company a “buy” rating in a report on Thursday. Finally, Piper Sandler lifted their price objective on shares of Intuitive Surgical from $595.00 to $610.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $602.32.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 336 shares of the business’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director owned 1,074 shares in the company, valued at $504,898.14. The trade was a 23.83% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 30,031 shares of company stock valued at $14,177,895. 0.70% of the stock is currently owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.